These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3104065)

  • 1. Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
    Wainwright CL; Parratt JR
    Eur J Pharmacol; 1987 Jan; 133(3):257-64. PubMed ID: 3104065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1985 Sep; 86(1):259-64. PubMed ID: 3840397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs.
    Végh A; Parratt JR
    Br J Pharmacol; 2002 Dec; 137(7):1107-15. PubMed ID: 12429584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
    Végh A; György K; Rastegar MA; Papp JG; Parratt JR
    Eur J Pharmacol; 1999 Oct; 382(2):81-90. PubMed ID: 10528142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of L655,240, a selective thromboxane and prostaglandin endoperoxide antagonist, on ischemia- and reperfusion-induced cardiac arrhythmias.
    Wainwright CL; Parratt JR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):264-71. PubMed ID: 2464097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ
    J Mol Cell Cardiol; 1984 Jul; 16(7):633-41. PubMed ID: 6433026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of PI 3-kinase/Akt pathway is involved in the acute effects of simvastatin against ischaemia and reperfusion-induced arrhythmias in anaesthetised dogs.
    Kisvári G; Kovács M; Seprényi G; Végh Á
    Eur J Pharmacol; 2015 Dec; 769():185-94. PubMed ID: 26597117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alifedrine, a positive inotropic agent that moderately reduces the severity of ischaemia and reperfusion-induced ventricular arrhythmias.
    Wainwright CL; Parratt JR
    Eur J Pharmacol; 1988 Mar; 147(3):373-80. PubMed ID: 3378563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists.
    Shaw LA; Coker SJ
    Br J Pharmacol; 1996 Mar; 117(5):817-22. PubMed ID: 8851496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
    Vegh A; Papp JG; Parratt J
    Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
    Fiedler VB; Perzborn E; Seuter F
    Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs.
    Rastegar MA; Végh A; Papp JG; Parratt JR
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):471-9. PubMed ID: 11101194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ICS 205-930, a 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Dean HG; Kane KA; Parratt JR
    Eur J Pharmacol; 1986 Aug; 127(3):211-8. PubMed ID: 3758180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role of inducible nitric oxide synthase activation in the delayed antiarrhythmic effect of sodium nitrite?
    Demeter-Haludka V; Juhász L; Kovác M; Gardi J; Végh Á
    Can J Physiol Pharmacol; 2017 Apr; 95(4):447-454. PubMed ID: 28177694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs.
    Nagy O; Hajnal A; Parratt JR; Végh A
    Br J Pharmacol; 2004 Feb; 141(4):549-51. PubMed ID: 14744808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity.
    Babai L; Papp JG; Parratt JR; Végh A
    Br J Pharmacol; 2002 Jan; 135(1):55-64. PubMed ID: 11786480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.